Results 291 to 300 of about 334,842 (343)

Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis. [PDF]

open access: yesJ Crohns Colitis
Reinisch W   +12 more
europepmc   +1 more source

Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Intravenous or oral steroid administration in patients with biliary atresia (BA) after Kasai hepatoportoenterostomy (HPE) is commonly practiced, however, the benefits remain controversial. Some studies suggest no positive effects while risking steroid associated side effects.
Stefanie Langreen   +8 more
wiley   +1 more source

Corticosteroids modulate biofilm formation and virulence of <i>Pseudomonas aeruginosa</i>. [PDF]

open access: yesBiofilm
Jordana-Lluch E   +13 more
europepmc   +1 more source

Upper extremity deep vein thrombosis associated with systemic lupus erythematosus and antiphospholipid syndrome

open access: yes
Journal of General and Family Medicine, EarlyView.
Masahiro Yabe   +6 more
wiley   +1 more source

Have we hit the JAK‐pot? Success of selective JAK 1 inhibitor following failure of pan‐JAK inhibitor in refractory pediatric ulcerative colitis

open access: yesJPGN Reports, EarlyView.
Abstract The treatment options available for pediatric ulcerative colitis (UC) are challenging due to few with Federal Drug Administration approval. Newer medications approved for adults include additional biologics with differing mechanisms of action and small molecule drugs, such as Janus kinase (JAK) inhibitors.
Jessica A. Black, Brad Pasternak
wiley   +1 more source

Home - About - Disclaimer - Privacy